RPS15AP18

Across TCGA pan-cancer cohorts, RPS15AP18 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated RPS15AP18 data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher RPS15AP18 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPS15AP18 expression acts as an unfavorable survival marker, although some lineages such as BRCA and READ show a favorable association.

KICH, SARC, and LUAD are the cancer types where RPS15AP18 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Tertile	II,III,IV	0.384	0.827	<.001	69	view →
SARC	OS	Tertile	All	0.292	0.565	<.001	36	view →
LUAD	DFS	Median	III,IV	0.276	0.592	.005	31	view →
BRCA	OS	Tertile	II,III,IV	0.942	0.897	.016	30	view →
UCEC	OS	Tertile	All	0.805	0.891	.005	30	view →
READ	DFS	Tertile	IV	1.000	0.469	.008	21	view →
THYM	OS	Tertile	III,IV	0.212	1.000	.014	18	view →
COAD	OS	Tertile	IV	0.925	0.529	.012	18	view →
SKCM	DFS	Median	IV	0.763	0.187	.006	12	view →
LAML	DFS	Quartile	All	0.491	0.250	.009	12	view →
PAAD	DFS	Tertile	III,IV	0.152	0.821	.045	9	view →
TGCT	DFS	Median	All	0.883	0.728	.018	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

RPS15AP18–KICH (DFS)

Open the KICH breakdown →